FN2 Earnings Intelligence

BioNTech SE earnings overview

Latest BioNTech SE (BNTX) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.

Next reportBioNTech SE reports Tuesday, Nov 3, 2026 · Before market openConsensus EPS $0.85 · consensus revenue $1.17B
BNTX FY2026 Q3 · Calendar Q4 2026

BioNTech SE

The quarter’s strongest strategic signal is BioNTech’s attempt to translate late-stage oncology progress into a broader multi-product business, while raised full-year revenue guidance provides near-term support. That case remains dependent on clinical execution and regulatory progress as COVID vaccine demand declines.

EPS surprise—
Market move-0.7%

Get the BNTX recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.